The effect of 1α(OH)D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy
- 1 January 1978
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 64 (1) , 101-107
- https://doi.org/10.1016/0002-9343(78)90184-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- 1,25 Dihydroxy-Vitamin D3 in Normal Man and Patients with Renal FailureAnnals of Internal Medicine, 1974
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManNew England Journal of Medicine, 1972
- Vitamin D, the kidney and calcium homeostasisKidney International, 1972
- Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic ratsJournal of Clinical Investigation, 1972
- Azotaemic renal osteodystrophyClinics in Endocrinology and Metabolism, 1972
- BONE DISEASE IN UREMIAAsaio Journal, 1972
- Vitamin D Metabolism in Experimental Uraemia: Effects on Intestinal Transport 45Ca and on Formation of 1,25-Dihydroxycholecalciferol in RatNature New Biology, 1971
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- Secondary Hyperparathyroidism in Chronic Renal FailureArchives of internal medicine (1960), 1969
- The role of the liver in the metabolism of vitamin DJournal of Clinical Investigation, 1969